Survey of Clinical Laboratory Practices for 2015 Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background: It is crucial to understand the current status of clinical laboratory practices for the largest outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in the Republic of Korea to be well prepared for future emerging infectious diseases. Methods: We conducted a survey of 49 clinical laboratories in medical institutions and referral medical laboratories. A short questionnaire to survey clinical laboratory practices relating to MERS-CoV diagnostic testing was sent by email to the directors and clinical pathologists in charge of the clinical laboratories performing MERS-CoV testing. The survey focused on testing volume, reporting of results, resources, and laboratory safety. Results: A total of 40 clinical laboratories responded to the survey. A total of 27,009 MERS-CoV real-time reverse transcription PCR (rRT-PCR) tests were performed. Most of the specimens were sputum (73.5%). The median turnaround time (TAT) was 5.29 hr (first and third quartile, 4.11 and 7.48 hr) in 26 medical institutions. The median TAT of more than a half of the laboratories (57.7%) was less than 6 hr. Many laboratories were able to perform tests throughout the whole week. Laboratory biosafety preparedness included class II biosafety cabinets (100%); separated pre-PCR, PCR, and post-PCR rooms (88.6%); negative pressure pretreatment rooms (48.6%); and negative pressure sputum collection rooms (20.0%). Conclusions: Clinical laboratories were able to quickly expand their diagnostic capacity in response to the 2015 MERS-CoV outbreak. Our results show that clinical laboratories play an important role in the maintenance and enhancement of laboratory response in preparation for future emerging infections.
Abstract
Background: It is crucial to understand the current status of clinical laboratory practices for the largest outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in the Republic of Korea to be well prepared for future emerging infectious diseases. Methods: We conducted a survey of 49 clinical laboratories in medical institutions and referral medical laboratories. A short questionnaire to survey clinical laboratory practices relating to MERS-CoV diagnostic testing was sent by email to the directors and clinical pathologists in charge of the clinical laboratories performing MERS-CoV testing. The survey focused on testing volume, reporting of results, resources, and laboratory safety. Results: A total of 40 clinical laboratories responded to the survey. A total of 27,009 MERS-CoV real-time reverse transcription PCR (rRT-PCR) tests were performed. Most of the specimens were sputum (73.5%). The median turnaround time (TAT) was 5.29 hr (first and third quartile, 4.11 and 7.48 hr) in 26 medical institutions. The median TAT of more than a half of the laboratories (57.7%) was less than 6 hr. Many laboratories were able to perform tests throughout the whole week. Laboratory biosafety preparedness included class II biosafety cabinets (100%); separated pre-PCR, PCR, and post-PCR rooms (88.6%); negative pressure pretreatment rooms (48.6%); and negative pressure sputum collection rooms (20.0%). Conclusions: Clinical laboratories were able to quickly expand their diagnostic capacity in response to the 2015 MERS-CoV outbreak. Our results show that clinical laboratories play an important role in the maintenance and enhancement of laboratory response in preparation for future emerging infections.
참고문헌 (12)
- Cowling BJ, "Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015", Euro Surveill, 20, pp.7~13 (2015)
- Hayden RT, "A survey-based assessment of United States clinical laboratory response to the 2009 H1N1 influenza outbreak", Arch Pathol Lab Med, 134, pp.1671~1678 (2010)
- Sullivan SJ, "2009 H1N1 influenza", Mayo Clin Proc, 85, pp.64~76 (2010)
- Crawford JM, "Laboratory surge response to pandemic (H1N1) 2009 outbreak, New York City metropolitan area, USA", Emerg Infect Dis, 16, pp.8~13 (2010)
- Lautenbach E, "Initial response of health care institutions to emergence of H1N1 influenza: experiences, obstacles, and perceived future needs", Clin Infect Dis, 50, pp.523~527 (2010)
- Lee WG, "Clinical pathology laboratory inspection and accreditation in Korea I: Development of the system and its trial", Korean J Clin Pathol, 21, pp.86~92 (2001)
- Oboho IK, "2014 MERS-CoV outbreak in Jeddah--a link to health care facilities", N Engl J Med, 372, pp.846~854 (2015)
- Tartari E, "Preparedness of institutions around the world for managing patients with Ebola virus disease: an infection control readiness checklist", Antimicrob Resist Infect Control, 4, pp.22~ (2015)
- Breban R, "Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk", Lancet, 382, pp.694~699 (2013)
- Pereyaslov D, "Laboratory capability and surveillance testing for Middle East respiratory syndrome coronavirus infection in the WHO European Region, June 2013", Euro Surveill, 19, pp.20923~ (2014)
- de Sousa R, "MERS coronavirus: data gaps for laboratory preparedness", J Clin Virol, 59, pp.4~11 (2014)
- Meltzer MI, "Laboratory surge capacity and pandemic influenza", Emerg Infect Dis, 16, pp.147~148 (2010)